BRIEF-ASP Isotopes Announces Proposed Merger Of Noble Africa With Endra Life Sciences

ENDRA Life Sciences Inc.
ASP Isotopes, Inc.

ENDRA Life Sciences Inc.

NDRA

0.00

ASP Isotopes, Inc.

ASPI

0.00

June 25 (Reuters) - ASP Isotopes Inc ASPI.O:

  • ASP ISOTOPES ANNOUNCES PROPOSED MERGER OF NOBLE AFRICA WITH ENDRA LIFE SCIENCES AND APPROXIMATELY $50 MILLION CONCURRENT PRIVATE PLACEMENT FINANCING

  • ASP ISOTOPES - COMBINED COMPANY TO OPERATE AS NOBLE AFRICA AND APPLY TO TRADE AS NOBA ON NASDAQ

  • ASP ISOTOPES - TO OWN ABOUT 89% OF COMBINED COMPANY AFTER MERGER

  • ASP ISOTOPES - NOBLE AFRICA SECURES $50 MILLION PRIVATE PLACEMENT COMMITMENTS

  • ASP ISOTOPES - PAUL E. MANN TO SERVE AS CEO, NICK MITCHELL AS COO OF COMBINED COMPANY

  • ASP ISOTOPES - ENDRA STOCKHOLDERS TO OWN 3%, PRIVATE PLACEMENT INVESTORS TO OWN 7% OF COMBINED COMPANY

  • ASP ISOTOPES - TO INVEST $20 MILLION AS LEAD INVESTOR IN PRIVATE PLACEMENT

Source text: ID:nGNX55FKDr

Further company coverage: ASPI.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.